FDA to Offer Faster Drug Reviews to Companies Promoting ‘National Priorities’

(MedPage Today) — U.S. regulators will begin offering faster reviews to new medicines that administration officials deem as promoting “the health interests of Americans,” under a new initiative announced Tuesday.
FDA Commissioner Marty Makary…